Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases.
$114.41+5.19%
报价 2026-11-06
市值
$25.1B
EV
$24.01B
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -45.9%
$91.88$211.41
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-07不在筛选范围：industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| INSMInsmed Incorporated | $25.1B | +5.2% | +191.4% | 84.3% | – | – | – | |
| TAKTakeda Pharmaceutical Company Limited | $66.35B | -0.8% | – | 59.5% | 79.2x | 9.8x | – | |
| CAHCardinal Health, Inc. | $62.92B | +1.5% | +3.9% | 4.3% | 31.6x | 16.9x | 11.9x | |
| HUMHumana Inc. | $52.08B | +5.3% | +25.8% | 11.7% | 41.8x | 17.8x | 69.7x | |
| AAgilent Technologies, Inc. | $49.28B | +1.7% | +6.1% | 26% | 27.1x | 23.0x | 39.3x | |
| IQVIQVIA Holdings Inc. | $44.8B | +2.6% | +8.0% | 32.9% | 33.1x | 16.6x | 16.9x | |
| ONCBeOne Medicines Ltd. | $43.49B | +5.1% | – | 86.9% | 160.5x | 56.0x | – | |
| HLNHaleon plc | $40.19B | -0.1% | – | 61.8% | 21.8x | 14.3x | – | |
| GEHCGE HealthCare Technologies Inc. | $37.25B | -1.6% | +6.5% | 40.3% | 21.3x | 14.0x | 30.9x | |
| 同行中位数 | – | – | +6.5% | 36.6% | 32.3x | 16.8x | 30.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。